» Articles » PMID: 26631911

Tyrosine Kinase 2 - Surveillant of Tumours and Bona Fide Oncogene

Overview
Journal Cytokine
Date 2015 Dec 4
PMID 26631911
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Tyrosine kinase 2 (TYK2) is a member of the Janus kinase (JAK) family, which transduces cytokine and growth factor signalling. Analysis of TYK2 loss-of-function revealed its important role in immunity to infection, (auto-) immunity and (auto-) inflammation. TYK2-deficient patients unravelled high similarity between mice and men with respect to cellular signalling functions and basic immunology. Genome-wide association studies link TYK2 to several autoimmune and inflammatory diseases as well as carcinogenesis. Due to its cytokine signalling functions TYK2 was found to be essential in tumour surveillance. Lately TYK2 activating mutants and fusion proteins were detected in patients diagnosed with leukaemic diseases suggesting that TYK2 is a potent oncogene. Here we review the cell intrinsic and extrinsic functions of TYK2 in the characteristics preventing and enabling carcinogenesis. In addition we describe an unexpected function of kinase-inactive TYK2 in tumour rejection.

Citing Articles

TYK2 :p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels.

Steri M, Orru V, Sidore C, Mulas A, Pitzalis M, Busonero F Immunology. 2025; 174(4):462-469.

PMID: 39835539 PMC: 11885862. DOI: 10.1111/imm.13902.


SS18-SSX drives TYK2 expression to activate STAT3/Bcl2 axis, facilitating apoptosis evasion and advancing synovial sarcoma progression.

Qin W, Peng C, Yang X, Jiang A, Zhong N, Liu Y Cell Biol Toxicol. 2024; 41(1):8.

PMID: 39707021 PMC: 11662063. DOI: 10.1007/s10565-024-09952-8.


TYK2 signaling promotes the development of autoreactive CD8 cytotoxic T lymphocytes and type 1 diabetes.

Mine K, Nagafuchi S, Akazawa S, Abiru N, Mori H, Kurisaki H Nat Commun. 2024; 15(1):1337.

PMID: 38351043 PMC: 10864272. DOI: 10.1038/s41467-024-45573-9.


The positive feedback loop of MAD2L1/TYK2/STAT3 induces progression in B-cell acute lymphoblastic leukaemia.

Zhu L, Li X, Liu D, Bai W, Yang H, Cheng Q J Cancer Res Clin Oncol. 2023; 149(9):6527-6540.

PMID: 36781502 DOI: 10.1007/s00432-023-04613-5.


Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach.

Gong X, Ren F Dis Markers. 2022; 2022:5239033.

PMID: 35711568 PMC: 9197628. DOI: 10.1155/2022/5239033.